Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
10/10/2017 10/11/2017 10/12/2017 10/13/2017 10/16/2017 Date
78.4(c) 78.75(c) 80.55(c) 78.75(c) 79(c) Last
54 305 105 461 165 700 206 055 72 167 Volume
-0.95% +0.45% +2.29% -2.23% +0.32% Change
More quotes
Financials (€)
Sales 2017 641 M
EBIT 2017 200 M
Net income 2017 136 M
Finance 2017 132 M
Yield 2017 1,13%
Sales 2018 708 M
EBIT 2018 223 M
Net income 2018 152 M
Finance 2018 232 M
Yield 2018 1,22%
P/E ratio 2017 32,15
P/E ratio 2018 28,86
EV / Sales2017 6,69x
EV / Sales2018 5,92x
Capitalization 4 420 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.Its business segments are the geographic locations in which it operates: Italy and the United Kingdom; Europe which comprises Germany, France, Belgium, the Netherlands, Spain, Portugal,... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
09/29 DIASORIN : Revises its guidance upwards for 2019 as a consequence of the complet..
09/29 DIASORIN : Completes the acquisition of the elisa immunodiagnostic business port..
09/21 DIASORIN : earned CE-mark extending sample claims for DiaSorin Molecular's Simpl..
09/05 DIASORIN : Tecan Collaborate in Molecular Platform Development
07/28 DIASORIN LAUNCHES 3 NEW PRIMER PAIRS : Pneumocystis jirovecii, group c streptoco..
07/25 DIASORIN : To acquire elisa immunodiagnostic business portfolio and associated a..
07/10 DIASORIN : launches IAM CBFB-MYH11, completing the diagnostic test menu for mole..
07/06 DIASORIN : Showcases the Benefits of Utilizing Available Biomarkers to Tailor an..
06/30 DIASORIN : Authorizations of Emergency Use of In Vitro Diagnostic Devices for De..
06/30 DIASORIN : and Tecan to collaborate in new platform development
More news
Sector news : Diagnostic & Testing Substances
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16DJDentsply Sirona General Counsel Exits, Marking Fourth Resignation in Recent W..
10/13 Toshiba discussing joint investment in chips with Western Digital
10/11 Mondi drags on FTSE, Provident Financial sinks
10/10 SMITH & NEPHEW : Elliott Management builds stake in Smith & Nephew - Bloomberg
More sector news : Diagnostic & Testing Substances
Latest Tweets
10/07DIASORIN SPA EUR1 upgraded by Zacks Investment Research to buy. $99.00 PT.  
09/23Global Thyroid Functioning Tests Market 2017-2021 with Abbott, bioMrieux, Dan.. 
09/22Global Thyroid Functioning Tests Market 2017-2021 with Abbott, bioMrieux, Dan.. 
09/21DiaSorin : earned CE-mark extending sample claims for DiaSorin Molecular's Si.. 
07/25DiaSorin fa shopping da Siemens Healthcare per 47,5 milioni  
More tweets
Qtime:36
News from SeekingAlpha
06/27 DiaSorin (DSRLF) Investor Presentation - Slideshow
2016 Winner And Losers Among Italian Companies
2016 Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides
2016 DiaSorin buys Quest's diagnostic products business for $300M
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 9
Average target price 72,6 €
Spread / Average Target -8,1%
EPS Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Francesco Colotta Chief Medical Officer & Senior Corporate VP
Chen Menachem Even Executive Director & SVP-Commercial Operations
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA40.00%5 202
BIOMERIEUX49.96%9 923
AUTOBIO DIAGNOSTICS CO LTD-9.37%3 217
MACCURA BIOTECHNOLOGY CO LTD--.--%2 287
SHANGHAI KEHUA BIO-ENGINEERING CO LTD--.--%1 392
SIEGFRIED HOLDING AG51.17%1 391